Crexont Capsule, Extended Release
Product Images NDC 64896-967

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Crexont (NDC 64896-967). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cd Structural Formula (Crexont Carbidopa And Levodopa Extended Release Ca 1)

Chemical structure of carbidopa, showing its molecular arrangement including hydroxyl groups, benzene ring, and hydrazine functional group, with associated water molecule (H2O). This corresponds to the active ingredient in CREXONT extended-release capsules by Amneal Pharmaceuticals LLC.*

FDA Label Image

Ld Structural Formula (Crexont Carbidopa And Levodopa Extended Release Ca 2)

Chemical structure diagram of levodopa, showing its molecular arrangement with a benzene ring and attached functional groups including hydroxyl, amine, and carboxyl groups.*

FDA Label Image

35-140 Ifc (Crexont Carbidopa And Levodopa Extended Release Ca 3)

Packaging label for CREXONT extended-release capsules containing carbidopa and levodopa. This label shows the 35 mg/140 mg strength, with the NDC number 64896-967-16. The label includes capsule images, storage instructions, and the Amneal Pharmaceuticals LLC logo on a yellow background. The package contains 120 capsules and is marked Rx only.*

FDA Label Image

52-5-210 Ifc (Crexont Carbidopa And Levodopa Extended Release Ca 4)

Carton packaging label for CREXONT extended-release capsules, containing 52.5 mg of carbidopa and 210 mg of levodopa. The label displays the brand name CREXONT in green and blue text, with dosage strength prominently in green. It also includes the labeler information for Amneal Pharmaceuticals LLC and storage instructions. The package size is 120 capsules with the NDC 64896-968-16.*

FDA Label Image

70-280 Ifc (Crexont Carbidopa And Levodopa Extended Release Ca 5)

Packaging label for CREXONT 70 mg/280 mg extended-release capsules containing carbidopa and levodopa. The label features the brand name CREXONT with dosage strength prominently displayed, dosage form as extended-release capsules, and includes storage instructions. The labeler is Amneal Pharmaceuticals LLC. The package count is 120 capsules, and the label includes a small capsule image and barcode.*

FDA Label Image

87-5-350 Ifc (Crexont Carbidopa And Levodopa Extended Release Ca 6)

Packaging label for CREXONT 87.5 mg/350 mg capsules, extended-release, containing carbidopa and levodopa. The label displays the proprietary name CREXONT with dosage strength and an image of a capsule. It includes storage instructions, prescription status (Rx only), and distributor information for Amneal Pharmaceuticals LLC. The package size indicated is 120 capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.